Drug: Tenofovir/Emtricitabine Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 28 Number of Pages: 2
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
127784801 | Tenofovir/Emtricitabine | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160926 | US | |
127784811 | Tenofovir/Emtricitabine | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160926 | US | |
127882441 | Tenofovir/Emtricitabine | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160928 | US | |
127882521 | Tenofovir/Emtricitabine | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160928 | US | |
127883271 | Tenofovir/Emtricitabine | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160928 | US | |
127908441 | Tenofovir/Emtricitabine | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160929 | US | |
127908521 | Tenofovir/Emtricitabine | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160929 | US | |
127908621 | Tenofovir/Emtricitabine | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160929 | US |
Total Records: 28 Number of Pages: 2